Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Prescription Digital Therapeutics
All Newsletters
214 articles
18 of 22
What Otsuka bid for Proteus. Important DTx study begins.
7.01.20
6
min. Read
Secret JNJ health-tech acquisition. VA talks Nest Health?
6.26.20
8
min. Read
Preview of Proteus Report. Akili gets FDA OK (finally).
6.20.20
3
min. Read
Thanks to Apple, Alivecor goes more DTC. Part II: Software as a drug.
6.05.20
7
min. Read
Part 1: How one digital therapy got an NDC, and why it will be the last.
5.29.20
6
min. Read
Senate bill seeks Rx digital therapeutic Medicare reimbursement.
5.15.20
6
min. Read
Novartis-Propeller near commercial launch. 5 biz models for MSK.
5.08.20
9
min. Read
Roche VR autism DTx. Pear pre-FDA launch. Welldoc reunion.
5.01.20
6
min. Read
Akili launches pre-FDA. Korea OKs Samsung BP app.
4.24.20
3
min. Read
Analysis: FDA’s new guidance for digital therapeutics
4.17.20
10
min. Read
1 of 22